Use of the drug MDMA, commonly known as ecstasy, may lead to lasting difficulties with learning and memory that persist long after a person stops taking it. A new analysis indicates that people who ...
A new study suggests that the long-term antidepressant effects of psychedelics may be driven by persistent changes in how ...
Obstructive sleep apnea (OSA) can affect moods and lead to chronic stress through disrupted sleep, oxygen deprivation, and ...
News-Medical.Net on MSN
Short-duration psychedelic therapy shows promise for major depression treatment
By Tarun Sai Lomte A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for larger ...
Taking or not taking ADHD medication can have some important real-life consequences that extend into the realms of education, ...
A millisecond delay in the speed of nerve impulses from the legs of a jogger can lead to a loss of balance with the potential for a severe or even fatal fall; a disturbance in the smooth interplay of ...
News-Medical.Net on MSN
Tiny organism offers insight into neurological side effects of chemotherapy
Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant ...
Researchers reported rapid, significant improvement in depression, with the benefits lasting for months after treatment.
Short-term bond ETFs are low-risk, offering modest yields and high liquidity. Vanguard's Short-Term Bond ETF (BSV) is known for low fees and broad asset diversification. SPDR's High-Yield Bond ETF ...
Short-term business financing can help you weather a cash crunch or take advantage of new opportunities, but these loans can come with high costs Written By Written by Staff Senior Editor, Buy Side ...
A FORMER French senator has been been found guilty of drugging a fellow politician to try and sexually assault her. Joël Guerriau, 68, was found guilty of spiking a glass of champagne which he gave to ...
Researchers at Scripps Research have redesigned fentanyl at the molecular level, challenging decades-old assumptions about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results